Ascletis-B (01672) spent approximately HKD 1.9327 million to repurchase 200,000 shares on October 31st.
Ka Li Pharmaceutical-B (01672) announced on October 31, 2025 the repurchase of about HK$1.9327 million...
ASCLETIS-B (01672) announced the repurchase of 200,000 shares for approximately HK$1.9327 million on October 31, 2025.
Related Articles
Amazon.com, Inc. (AMZN.US) stock price hits three-year high, analysts raise target price to $290.
US Stock Market Move | Tesla, Inc. (TSLA.US) rose nearly 4% as Morgan Stanley significantly raised its target price to $800.
Alphabet (GOOG.US, GOOGL.US) performance greatly exceeds expectations, stock price reaching all-time high. Analysts unanimously bullish on its AI and cloud business.
Amazon.com, Inc. (AMZN.US) stock price hits three-year high, analysts raise target price to $290.
US Stock Market Move | Tesla, Inc. (TSLA.US) rose nearly 4% as Morgan Stanley significantly raised its target price to $800.
Alphabet (GOOG.US, GOOGL.US) performance greatly exceeds expectations, stock price reaching all-time high. Analysts unanimously bullish on its AI and cloud business.
RECOMMEND
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025
Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025
Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025
